Strategic CRISPR & Gene Editing Technology ETF (XDNA)

13.81 ↑0.55 (4.11%)
As of Market Close on January 26th, 2022.

XDNA Chart

Your browser does not support this chart.

Your browser does not support this chart.

  • 52-Week Range: $0.00 - $0.00
  • Market Capitalization: $0
  • Short Percentage: 0%
  • Target Price: N/A
  • Shares Outstanding: 0
  • Next Earnings: N/A
View More Stats

News and Press Releases

Company Info

Website: N/A
Address: N/A
Sector: N/A
Industry: N/A
Full time employees: N/A

Stock Details

  • Current Price: $13.81
  • 52-Week Low: $0.00
  • 52-Week High: $0.00
  • Most Recent Quarter: 0000-00-00
  • Shares Float: 0
  • Shares Outstanding: 0
  • Market Capitalization: $0
  • Next Earnings Date: N/A

Short Interest

  • Shares Short
    (Today):
    0
  • Short Ratio: 0.00
  • Shares Short
    (Last Month):
    0
  • Short Interest: 0.00%

The short interest for Strategic CRISPR & Gene Editing Technology ETF is at 0.00%, which is low amongst its peers.

Stock Ownership

Your browser does not support this chart.

Retail: 100.00%
Insiders: 0.00%
Instutitions: 0.00%

Analyst Target Price

0.00

Strategic CRISPR & Gene Editing Technology ETF is currently $13.26 above Wallstreet Analysts' price target.

Yesterday's Volume

372

Interest in Strategic CRISPR & Gene Editing Technology ETF has been trending down. The average daily volume in the past 14 days is 769.

Discussions

Please log in or register to share your thoughts.

No comments yet. Be the first.